Objectives: 

1. Articulate physiology of SGLT2 inhibitors on the kidney and glucose balance

2.Verbalize data from outcome trials using SGLT2 inhibitors on CV outcome

3. Describe data from outcome trials using SGLT2 inhibitors on renal outcomes and mechanisms

 

Session date: 
Friday, April 27, 2018 - 8:00am to 9:00am
Speaker Name: 
George L. Bakris, MD
Location: 
NorthShore - Evanston
Evanston, IL 60201
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.